论文部分内容阅读
Objective Background: Paclitaxel/cisplatin is one of the standard chemotherapies for non–small cell lung carcinoma.However,the solvents related adverse effects such as severe allergic reaction,histamine release and irreversible neurotoxicity may threaten to life.